Holders over time
- CVS
- KO
| Quarter | CVS | KO |
|---|---|---|
| Q3 2020 | 29 holders, $8.9bn | 30 holders, $34.7bn |
| Q4 2020 | 22 holders, $9.8bn | 30 holders, $39.2bn |
| Q1 2021 | 28 holders, $10.3bn | 30 holders, $37.6bn |
| Q2 2021 | 24 holders, $11.8bn | 30 holders, $38.0bn |
| Q3 2021 | 28 holders, $11.9bn | 34 holders, $37.9bn |
| Q4 2021 | 28 holders, $14.7bn | 33 holders, $43.3bn |
| Q1 2022 | 25 holders, $14.4bn | 32 holders, $45.4bn |
| Q2 2022 | 30 holders, $13.5bn | 30 holders, $45.1bn |
| Q3 2022 | 28 holders, $13.9bn | 34 holders, $39.8bn |
| Q4 2022 | 30 holders, $12.6bn | 37 holders, $44.1bn |
| Q1 2023 | 36 holders, $9.6bn | 37 holders, $42.2bn |
| Q2 2023 | 33 holders, $9.8bn | 36 holders, $40.8bn |
| Q3 2023 | 33 holders, $11.7bn | 36 holders, $37.8bn |
| Q4 2023 | 32 holders, $14.2bn | 34 holders, $38.4bn |
| Q1 2024 | 21 holders, $14.3bn | 33 holders, $41.0bn |
| Q2 2024 | 24 holders, $14.2bn | 33 holders, $43.4bn |
| Q3 2024 | 31 holders, $14.2bn | 26 holders, $47.9bn |
| Q4 2024 | 32 holders, $11.0bn | 33 holders, $42.2bn |
| Q1 2025 | 29 holders, $19.1bn | 33 holders, $47.1bn |
| Q2 2025 | 31 holders, $19.6bn | 36 holders, $48.4bn |
| Q3 2025 | 28 holders, $21.9bn | 36 holders, $44.4bn |
| Q4 2025 | 29 holders, $22.8bn | 36 holders, $47.5bn |
| Q1 2026 | 32 holders, $21.1bn | 34 holders, $52.4bn |
| Q2 2026 | 31 holders, $30.8bn | 34 holders, $56.1bn |
CVS Health Corp
- Holders
- 31
- Reported value
- $14.2bn
- Buyers
- 23
- Sellers
- 10
Breadth +13 among 94 comparable managers.
Coca Cola Co
- Holders
- 26
- Reported value
- $47.9bn
- Buyers
- 7
- Sellers
- 19
Breadth -12 among 94 comparable managers.
Who holds both, Q3 2024
Both (15)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), GAMCO Investors Inc, Invesco Ltd, Janus Henderson Group Ltd, Marshall Wace LLP, Point72 Asset Management LP, T. Rowe Price Associates Inc
Only CVS (16)
Balyasny Asset Management LLC, Caxton Associates LLP, Eisler Capital Management Ltd, Glenview Capital Management LLC, Harris Associates LP, Millennium Management LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Sachem Head Capital Management LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Third Point LLC, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, Voloridge Investment Management LLC
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.